BIIB036

N/A

Report date: 2026/03/12 20:00:16

Base Information

Drug NameBIIB036
Drug Alias NameBIIB-036
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 12A inhibitors
TargetsTumor necrosis factor receptor superfamily member 12A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiogen Idec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiogen Idec
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A